In this podcast, Motley Fool analysts Asit Sharma, Ron Gross, and Matt Argersinger talk about: Market volatility. Inflation.

Whatever is good for CoreWeave is probably good for Core Scientific, but the IPO might not be the most important recent ...

It’s easy to interpret CoreWeave’s lackluster IPO and muted first day of trading on Friday as bad news for the entire AI boom ...

CoreWeave's stock plunged nearly 10% on Monday, dropping below its IPO price, raising concerns about AI-focused IPOs in a ...

The most anticipated tech-related IPO in recent memory has turned into a dud of sorts. And at least two well-known hedge ...

CoreWeave reduced the size of its U.S. initial public offering and priced its shares below the indicated range, the company ...

CoreWeave's IPO debuted at $40 per share, raising $1.5 billion, which is down a billion from the initial goal. Check out our ...

CoreWeave is targeting a valuation of up to $32 billion on a fully diluted basis in its U.S. initial public offering, as the ...

CoreWeave’s Nasdaq debut may offer hope to other IPO candidates that smooth listings are achievable with tempered valuations, ...

Madison Mills breaks down the top stories on Monday morning on this segment of Market Minute, including Nvidia's (NVDA) and ...

Nvidia Corporation (NASDAQ: NVDA) dropped 3.66% during the Monday pre-market trading session following CoreWeave's ...

“CoreWeave’s IPO likely will have a correlating impact on Core Scientific,” Wolfie ... “However, if the AI market experiences a downturn or the demand for high-performance computing ...